## Clinical Context This is a life-threatening hemorrhage scenario where O Rh-negative blood was unavailable and O Rh-positive blood was transfused to an Rh-negative woman. The question tests understanding of transfusion priorities in emergencies and Rh sensitization prevention. ## Key Principle: Life-Saving Transfusion Takes Priority **Key Point:** In acute, life-threatening hemorrhage, transfusion of incompatible blood (in this case, Rh-positive to Rh-negative) is justified when compatible blood is unavailable. The immediate goal is to restore circulating volume and oxygen-carrying capacity to prevent death. ## Management Strategy **High-Yield:** The correct approach is: 1. **Continue O Rh-positive transfusion** — the patient remains critically hypotensive and anemic; further delay increases mortality risk 2. **Administer anti-D immunoglobulin (RhIG)** — given within 72 hours (ideally within 24 hours) to prevent Rh sensitization 3. **Calculate anti-D dose** — typically 100 IU per mL of fetal RBCs or 500 IU per mL of fetal plasma; a standard 500 IU dose covers ~2 mL of fetal RBCs **Clinical Pearl:** Rh sensitization is a delayed complication (develops over weeks to months). In an acutely exsanguinating patient, preventing immediate death supersedes the risk of future hemolytic disease in pregnancy. Anti-D administration mitigates the long-term immunological consequence. ## Why Other Options Fail | Option | Problem | |--------|----------| | Switch to O Rh-negative only | Delays resuscitation; O Rh-negative supply is precious and may be exhausted; patient is still critically unstable | | AB Rh-negative plasma only | Plasma alone does not restore hemoglobin; patient has severe anemia (Hb 7.5) requiring RBCs | | Exchange transfusion | Not indicated in acute hemorrhage; exchange transfusion is used for hemolytic disease of newborn or severe transfusion reactions, not for volume resuscitation | **Mnemonic: LIFE FIRST** — **L**ife-saving transfusion, **I**mmediate resuscitation, **F**uture sensitization prevention (anti-D), **E**arly administration (within 72 hrs), **S**ensitization avoided, **T**ransfusion continued until stable.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.